InvestSMART

Racura Oncology Ltd (ASX: RAC) - Announcements

- Current share price for RAC : $1.515

ASX company news and announcements for Racura Oncology Ltd (RAC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Racura Oncology Ltd (RAC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Racura Oncology Ltd (RAC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Racura Oncology Ltd (RAC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$297 Change of Share Registry Address 9 Dec 2016 1:36PM $0.210 $1.515 risen by 621.43%
$297 Appendix 3B 22 Nov 2016 5:49PM $0.225 $1.515 risen by 573.33%
$297 Results of AGM 21 Nov 2016 11:19AM $0.210 $1.515 risen by 621.43%
$297 Appendix 4C - quarterly 25 Oct 2016 4:28PM $0.260 $1.515 risen by 482.69%
$297 Race Signs Agreement with US Based IriSys LLC 25 Oct 2016 9:31AM $0.250 $1.515 risen by 506%
$297 Second US Oncologist Joins Race Scientific Advisory Team 24 Oct 2016 9:45AM $0.235 $1.515 risen by 544.68%
$297 Annual Report to Shareholders 20 Oct 2016 4:37PM $0.230 $1.515 risen by 558.70%
$297 Notice of Annual General Meeting/Proxy Form 20 Oct 2016 4:32PM $0.230 $1.515 risen by 558.70%
$297 Race Signs Key Manufacturing Agreement for Bisantrene 5 Oct 2016 9:31AM $0.230 $1.515 risen by 558.70%
$297 Leading US Oncolcogist Joins Race Scientific Advisory Team 4 Oct 2016 9:45AM $0.230 $1.515 risen by 558.70%
$297 Race Signs NPP Partnership with CarthaGenetics in Europe 5 Sep 2016 8:33AM $0.240 $1.515 risen by 531.25%
$297 Appendix 4G 29 Aug 2016 4:37PM $0.220 $1.515 risen by 588.64%
$297 Appendix 4E & Financial Statements 29 Aug 2016 4:36PM $0.220 $1.515 risen by 588.64%
$297 Race Appoints Head of European Marketing Operations 22 Aug 2016 9:27AM $0.210 $1.515 risen by 621.43%
$297 Leading Oncologist Joins Race Scientific Team 19 Aug 2016 9:36AM $0.210 $1.515 risen by 621.43%
$297 Resignation of Joint Company Secretary 15 Aug 2016 4:17PM $0.210 $1.515 risen by 621.43%
$297 Race signs two key consulting agreements 9 Aug 2016 9:22AM $0.240 $1.515 risen by 531.25%
$297 Race Oncology Releases Investor Presentation 3 Aug 2016 9:30AM $0.255 $1.515 risen by 494.12%
$297 Race signs agreement with Camargo Pharmaceutical 26 Jul 2016 9:21AM $0.260 $1.515 risen by 482.69%
$297 Race signs agreement with Crystal Pharmatech 25 Jul 2016 9:26AM $0.275 $1.515 risen by 450.91%
$297 Investment Research Report 21 Jul 2016 11:02AM $0.250 $1.515 risen by 506%
$297 RAC responds to frequently asked questions from shareholders 20 Jul 2016 8:52AM $0.250 $1.515 risen by 506%
$297 Race Oncology MD Speaks to Finance News Network 19 Jul 2016 9:01AM $0.220 $1.515 risen by 588.64%
$297 Becoming a substantial holder 12 Jul 2016 6:02PM n/a $1.515 n/a
$297 Becoming a substantial holder 12 Jul 2016 6:02PM n/a $1.515 n/a

951 - 975 of 1002 results

Page 39 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.